Abbott, one of the biggest global healthcare companies in the world recently announced its release of a new inactivated quadrivalent vaccine against influenza and viruses in India.
Dr. Srirupa Das from Abbott, India says that this new particular type of vaccine will provide a good immune response with fewer side effects and can be offered to both children above six months and adults.
It is the only quadrivalent flu vaccine (0.5ml) that has been approved for use for those children aged below 3 years in India.
This is another step in Abbott’s mission to guard as many people as possible against influenza that have caused infectious respiratory diseases in many people.
Abbott India was established in 1920 and has since then grown to have over 12,000 employees in the country.